Bayer Income from Continuous Operations 2010-2024 | BAYRY

Bayer income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change

Bayer Income from Continuous Operations 2010-2024 | BAYRY

Bayer income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$872.5B
Novo Nordisk (NVO)$529.9B
Johnson & Johnson (JNJ)$397.5B
AbbVie (ABBV)$333.6B
Merck (MRK)$275.3B
AstraZeneca (AZN)$242.7B
Novartis AG (NVS)$239.5B
Pfizer (PFE)$165.6B
Sanofi (SNY)$139.4B
Innoviva (INVA)$1.3B